CONGENITAL GENERALISED LIPODYSTROPHY

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting CONGENITAL GENERALISED LIPODYSTROPHY:

# Drug Count
0 ZIDOVUDINE 4
1 ABACAVIR SULFATE 2
2 DARUNAVIR 2
3 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 2
4 ETRAVIRINE 2
5 LAMIVUDINE AND ZIDOVUDINE 2
6 RITONAVIR 2
7 0XYGEN 1
8 ACARBOSE 1
9 EZETIMIBE 1
See all common drugs associated with CONGENITAL GENERALISED LIPODYSTROPHY

CONGENITAL GENERALISED LIPODYSTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELFINAVIR MESYLATE 1 0.0005
1 ETRAVIRINE 2 0.0005
2 NITROUS OXIDE 1 0.0005
3 ZIDOVUDINE 4 0.0004
4 LAMIVUDINE AND ZIDOVUDINE 2 0.0003
5 ACARBOSE 1 0.0003
6 ABACAVIR SULFATE 2 0.0002
7 RALTEGRAVIR 1 0.0002
8 DARUNAVIR 2 0.0001
9 PHYTONADIONE 1 0.0001
See all drugs enriched for association with CONGENITAL GENERALISED LIPODYSTROPHY